Mylan's Robert Coury - CEO Pay
Robert Coury - Mylan
Total Compensation: $12.5M
Details: Coury didn't make out as well as some of his colleagues at Mylan who received 70 to 113 percent raises, but he was awarded a 20 percent increase over his 2007 pay. The Chief received $1,500,000 in base salary and $3,750,000 in incentives--over 80 percent more than 2007's bonus. Coury's stock and options more than doubled to $5,230,000. The little perks stuffed into "other compensation" also jumped in 2008. In fact, those charges also doubled to $464,037, which included $26,787 for his company car, and $348,988 for personal use of the company airplane.
Mylan News:
Mylan execs' pay leaps by 41%
Mylan to cut 100 in Puerto Rico
Mylan CEO intent on new global biz
Mylan CEO makes $10M in 9 months
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: